BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Treps L, Faure S, Clere N. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target. Pharmacology & Therapeutics 2021;223:107805. [DOI: 10.1016/j.pharmthera.2021.107805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Matias M, Pinho JO, Penetra MJ, Campos G, Reis CP, Gaspar MM. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval. Cells 2021;10:3088. [PMID: 34831311 DOI: 10.3390/cells10113088] [Reference Citation Analysis]
2 Tan LY, Cockshell MP, Moore E, Myo Min KK, Ortiz M, Johan MZ, Ebert B, Ruszkiewicz A, Brown MP, Ebert LM, Bonder CS. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. OncoImmunology 2022;11:2043673. [DOI: 10.1080/2162402x.2022.2043673] [Reference Citation Analysis]
3 Song X, An Y, Chen D, Zhang W, Wu X, Li C, Wang S, Dong W, Wang B, Liu T, Zhong W, Sun T, Cao H. Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Sci 2021. [PMID: 34811848 DOI: 10.1111/cas.15208] [Reference Citation Analysis]
4 Chen Y, Lu X, Gao L, Dean DC, Liu Y. Spheroid-induced heterogeneity and plasticity of uveal melanoma cells. Cell Oncol (Dordr) 2022. [PMID: 35404029 DOI: 10.1007/s13402-022-00671-y] [Reference Citation Analysis]
5 Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D'Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci 2021;15:703431. [PMID: 34867197 DOI: 10.3389/fncel.2021.703431] [Reference Citation Analysis]
6 Delprat V, Michiels C. A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression. Cancer Metastasis Rev 2021;40:477-500. [PMID: 33783686 DOI: 10.1007/s10555-021-09958-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pagano C, Navarra G, Pastorino O, Avilia G, Coppola L, Della Monica R, Chiariotti L, Florio T, Corsaro A, Torelli G, Caiazzo P, Gazzerro P, Bifulco M, Laezza C. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition. Int J Mol Sci 2021;22:10530. [PMID: 34638872 DOI: 10.3390/ijms221910530] [Reference Citation Analysis]
8 Vandyck HH, Hillen LM, Bosisio FM, van den Oord J, Zur Hausen A, Winnepenninckx V. Rethinking the biology of metastatic melanoma: a holistic approach. Cancer Metastasis Rev 2021;40:603-24. [PMID: 33870460 DOI: 10.1007/s10555-021-09960-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-bergami P, D'aguanno S. Bcl-2-like protein-10 increases aggressive features of melanoma cells. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00068] [Reference Citation Analysis]
10 Tang F, Tie Y, Wei YQ, Tu CQ, Wei XW. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer 2021;1876:188606. [PMID: 34371128 DOI: 10.1016/j.bbcan.2021.188606] [Reference Citation Analysis]